Funder: Childhood Arthritis and Rheumatology Research Alliance
Due Dates (Anticipated): January 2027 (Letter of Intent) | January 2027 (Data and Sample Share Request) | March 2027 (Application)
Funding Amounts: $125,000 per award for one year; two awards, including at least one focused on juvenile idiopathic arthritis
Summary: Bridge funding helps investigators address reviews of unfunded NIH or equivalent proposals and prepare revised submissions in pediatric rheumatic disease research.
Key Information: The PI must be a CARRA member in good standing, and resubmission is expected during the funding period.
Description
The CARRA–Arthritis Foundation Bridge Grant supports investigators whose K-equivalent career-development or R-equivalent investigator-initiated applications to the NIH or a similar funding body were reviewed but not funded. It provides support to address reviewers’ critiques substantively and strengthen a revised submission. The program description targets investigators intending to resubmit within 12–18 months, while the application instructions require resubmission during the one-year bridge funding period.
Research must advance CARRA’s mission to prevent, treat, and cure pediatric rheumatic diseases and align with its 2023–2025 Strategic Plan, Research Agenda, and CARRA–Arthritis Foundation Inflammatory Arthritis Research Agenda. The program prioritizes juvenile idiopathic arthritis (JIA), with at least one award designated for JIA research. Applicants must explain how their work will ultimately affect patients, directly or indirectly.
